Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration
2009

Using Optical Coherence Tomography to Study Eye Changes in Macular Degeneration

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Yi K, Mujat M, Park B H, Sun W, Miller J W, Seddon J M, Young L H, de Boer J F, Chen T C

Primary Institution: Harvard Medical School

Hypothesis

Can spectral domain optical coherence tomography (SDOCT) provide better evaluation of drusen and structural changes in non-neovascular age-related macular degeneration (AMD) compared to time domain optical coherence tomography (TDOCT)?

Conclusion

SDOCT with new algorithms can significantly improve the evaluation of structural abnormalities in non-neovascular AMD.

Supporting Evidence

  • SDOCT can achieve a 150-fold improvement in sensitivity compared to TDOCT.
  • New algorithms can automatically calculate drusen area and volume.
  • SDOCT images show fewer motion artifacts than TDOCT images.

Takeaway

This study shows that a new type of eye scan can help doctors see and measure bumps in the eye better, which can help them understand eye diseases.

Methodology

Images were obtained from three eyes of three patients with AMD using an experimental SDOCT system, and a qualitative and quantitative analysis was performed for structural changes.

Limitations

The study involved a small sample size of only three patients.

Participant Demographics

Three patients with non-neovascular AMD, including a 54-year-old black female, an 82-year-old Caucasian male, and a 58-year-old Caucasian male.

Digital Object Identifier (DOI)

10.1136/bjo.2008.137356

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication